Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisenn Lalier

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancers|June 28, 2023
Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 ExpressionGwenola Bougras-Cartron, Arulraj Nadaradjane, Marie-Pierre Joalland, et al.
Cell Death & Disease|February 16, 2021
TOM20-mediated transfer of Bcl2 from ER to MAM and mitochondria upon induction of apoptosisLisenn Lalier, Vincent Mignard, Marie-Pierre Joalland, et al.
Biochemical Pharmacology|November 12, 2018
Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancerFrançois M Vallette, Christophe Olivier, Frédéric Lézot, et al.
Nature Communications|November 22, 2025
Allosteric regulation of BH3-in-groove interactions by tail anchors of BCL-xL complexes limits BH3 mimetic antagonismLaurent Maillet, Aurélie Fétiveau, Lisenn Lalier, et al.
Journal of Lipid Research|May 1, 2020
Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosisVincent Mignard, Nolwenn Dubois, Didier Lanoé, et al.
The Journal of Biological Chemistry|July 12, 2012
Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applicationsMarie Morfouace, Lisenn Lalier, Muriel Bahut, et al.
Plos One|July 9, 2010
Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cellsEric Hervouet, Lisenn Lalier, Emilie Debien, et al.
Molecular Cancer Therapeutics|May 20, 2017
Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor ErlotinibJudith Raimbourg, Marie-Pierre Joalland, Mathilde Cabart, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancers|June 28, 2023
Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 ExpressionGwenola Bougras-Cartron, Arulraj Nadaradjane, Marie-Pierre Joalland, et al.
Cell Death & Disease|February 16, 2021
TOM20-mediated transfer of Bcl2 from ER to MAM and mitochondria upon induction of apoptosisLisenn Lalier, Vincent Mignard, Marie-Pierre Joalland, et al.
Biochemical Pharmacology|November 12, 2018
Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancerFrançois M Vallette, Christophe Olivier, Frédéric Lézot, et al.
Nature Communications|November 22, 2025
Allosteric regulation of BH3-in-groove interactions by tail anchors of BCL-xL complexes limits BH3 mimetic antagonismLaurent Maillet, Aurélie Fétiveau, Lisenn Lalier, et al.
Journal of Lipid Research|May 1, 2020
Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosisVincent Mignard, Nolwenn Dubois, Didier Lanoé, et al.
The Journal of Biological Chemistry|July 12, 2012
Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applicationsMarie Morfouace, Lisenn Lalier, Muriel Bahut, et al.
Plos One|July 9, 2010
Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cellsEric Hervouet, Lisenn Lalier, Emilie Debien, et al.
Molecular Cancer Therapeutics|May 20, 2017
Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor ErlotinibJudith Raimbourg, Marie-Pierre Joalland, Mathilde Cabart, et al.
Pageof 2